Zandu Ayurveda launches its first clinic at Nature Cure & Yoga Centre in Kolkata
Plans to launch more clinics in other select cities
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis
Expansion of product offerings with focus on cancer therapeutics drives M&A activity
India market sees no deals in August ‘13
Piramal Healthcare to invest $11 million at its UK facility
Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013
PSM India organises workshops on pharmacovigilance
Stakeholders across the spectrum deliberated on the current state of pharmacovigilance and ways to make the system stronger.…
National Forum on Tuberculosis holds first meeting in New Delhi
Discusses the rise and challenges of drug-resistant TB in India
OPPI seminar debates healthcare access in India
The event saw the presence of distinguished professionals, acclaimed experts and scientists from the Indian healthcare industry…
UK seeks to create healthy business environment with India
13 British pharma, life sciences and research organisations on a business visit to India
Safeguarding products is top challenge for Asia’s healthcare executives: Survey
Product security rises to top spot while regulatory compliance remains top concern
US FDA approves first generic capecitabine of Teva Pharmaceuticals
To treat colorectal and breast cancers
Debiopharm Group in research agreement with TCG Lifesciences
To develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm
WHO evaluates Panacea Biotec’s pentavalent vaccine
Successfully completes the audit of its Lalru and Baddi facilities, conducted by WHO team
Dr Yusuf Hamied, CMD, Cipla, to deliver first Margi Memorial lecture
Announcement will be made about the proposed Margi Patel Choksi Memorial IPR Foundation
Rupee’s fall from grace: A blessing in disguise?
How will the falling Rupee impact Indian pharma Inc? While some feel it's an unmitigated disaster, others call it a blessing in…
‘Companies need to proactively hedge their risks and minimise impact on their earnings’
The Indian rupee has depreciated significantly against the dollar, raising anxieties amongst many stakeholders in the country.…
‘Exports will encash the benefit’
Depreciating rupee shall have mixed impact on the sector. Companies which are highly dependent on exports or more than 50 per cent…
‘The rupee depreciation has happened at the wrong time for the pharma industry’
The Indian rupee is under great stress as overseas investors are paring their exposure to Asia’s third largest economy amid…
‘Rupee depreciation is expected to increase manufacturing costs’
The rupee’s weakness unfolded when it depreciated over 16 per cent against the US dollar between January 2013 and July 2013. With…